Table 3.
Metabolites | SC vs. RC | SC vs. URC | RC vs. URC | |||
---|---|---|---|---|---|---|
AUC | FC | AUC | FC | AUC | FC | |
Phenylethylamine | 0.83 | 0.16 | 0.70 | 0.50 | 0.79 | 1.06 * |
Cysteine | 0.56 | −0.12 | 0.84 | 0.70 * | 0.86 | 0.73 * |
Betaine | 0.58 | 0.01 | 0.85 | 0.32 * | 0.80 | 0.05 * |
Pipecolic acid | 0.56 | −0.02 | 0.83 | 0.97 * | 0.74 | 0.38 * |
TMAO | 0.69 | −0.26 | 0.63 | 0.29 | 0.75 | 0.40 |
3-Methylhistidine | 0.73 | 0.80 | 0.58 | 0.12 | 0.78 | 1.08 * |
PC 38:3 | 0.59 | 0.06 | 0.65 | −0.22 | 0.73 | −0.15 |
TG 42:0 | 0.53 | −0.47 | 0.67 | −1.21 | 0.74 | −0.45 |
TG 51:1(TG 16:0_17:0_18:1) | 0.68 | 0.58 | 0.59 | −0.30 | 0.71 | −0.90 |
Conduritol-beta-epoxide | 0.63 | 1.33 | 0.66 | −1.24 | 0.74 | −0.99 |
N-Acetylglycine | 0.64 | 0.10 | 0.63 | 0.16 | 0.76 | 0.84 |
TG 45:1(TG 12:0_16:0_17:1) | 0.60 | −0.24 | 0.51 | −0.56 | 0.74 | −0.30 |
PI 36:4 | 0.58 | 2.42 | 0.60 | −0.47 | 0.73 | −0.99 |
TG 46:2 | 0.61 | −0.99 | 0.68 | −0.49 | 0.67 | −1.79 |
TG 44:0 | 0.53 | −0.47 | 0.66 | −1.41 | 0.70 | −1.28 |
Pipecolinic acid | 0.50 | −0.23 | 0.74 | 0.98 | 0.74 | 1.99 |
Coniferyl aldehyde | 0.70 | −0.28 | 0.52 | −0.24 | 0.77 | 0.29 |
TG 54:5(TG 18:1_18:2_18:2) | 0.64 | −0.13 | 0.59 | 0.14 | 0.75 | −0.22 |
3-hydroxybutyric acid | 0.67 | −0.07 | 0.66 | 0.76 | 0.66 | −0.29 |
LPC 20:3 | 0.61 | −0.07 | 0.63 | 0.09 | 0.71 | −0.12 |
AUC-ROC curves were generated (cutoff: 0.7). *, p < 0.05. The data shown in the fold change (FC) column are relative to SC or RC. AUC, area under the curve; LPC, lysophosphatidylcholine; PC, phosphatidylcholine; PI, phosphatidylinositol; RC, refined carbohydrate diet; SC, simple carbohydrate diet; TG, triacylglycerol; TMAO, trimethylamine N-oxide; URC, unrefined carbohydrate diet.